hotspot -WSS

hotspot

author：Wikipedia 2025-09-27 12:56:43 - browse：87587

Light micrograph of a fatty liver — Large vacuoles of triglyceride fat, accumulated inside liver cells. Adobe

SAN DIEGO — An experimental obesity drug from Eli Lilly significantly reduced liver fat in a small analysis, supporting further studies of the treatment against nonalcoholic fatty liver disease, an increasingly common condition that lacks approved treatments.

Among 98 patients with nonalcoholic fatty liver disease, those on the highest dose tested of the drug, retatrutide, experienced an 86% decrease in liver fat over 48 weeks, with most of the reduction occurring early on in treatment, according to data presented here at the American Diabetes Association conference Monday.

Additionally, 93% of people on the highest dose achieved resolution of fatty liver disease, defined as having 5% or less liver fat.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： FDA panel to weigh safety of artificial wombs for preterm births

hotspot

entertainment

WSS

Medicare Advantage coverage denials need scrutiny, senators say

Medicare Advantage overpayments discussion gets experts fired up

Nonprofit, backed by Microsoft, to certify AI tools in health care

Grad students accuse University of California of wage theft

Study suggests new cause of Down syndrome: cells linked to aging

Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

focus

hotspot

entertainment

BioMarin wins approval for gene therapy to treat hemophilia A

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

After affirmative action ruling, medical educators look to 'holistic review'

Merck to acquire Harpoon Therapeutics for $680 million

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Male doctors called my cancer incurable. A female doctor showed it wasn't

Virginia high school admissions case could be legal follow

The unintended consequences of overturning Roe v. Wade

Sports medicine is finally prioritizing gender equality

Assistant physicians can help address the primary care shortage

focus

Stories you might have missed in 2023: health, science, medicine

Boston Scientific acquires urology company Axonics for $3.7 billion

FDA early review: GLP

House panel takes first step toward fixing drug shortages

Medicare to pay more for cardiac rehab in hospital outpatient clinics

Nonprofit, backed by Microsoft, to certify AI tools in health care

hotspot

entertainment

entertainment

hotspot